Literature DB >> 11487205

Deep brain stimulation of the subthalamic nucleus: selection of patients and clinical results.

L Lopiano1, M Rizzone, P Perozzo, A Tavella, E Torre, M Lanotte, B Bergamasco.   

Abstract

Deep brain stimulation of the subthalamic nucleus has been proved to be an effective treatment for advanced Parkinson's disease when therapeutical strategies have failed. A correct selection of candidates for surgery is fundamental to obtain a good clinical effect. In this study we present our protocol of patient selection. In addition we report the data relative to the different causes of exclusion and the clinical efficacy of the electrical stimulation of the subthalamic nucleus at 3 months and 1 year follow-up.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11487205     DOI： 10.1007/s100720170050

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  3 in total

1.  Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease.

Authors:  R R Goodman; B Kim; S McClelland; P B Senatus; L M Winfield; S L Pullman; Q Yu; B Ford; G M McKhann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

2.  Interdisciplinary Parkinson's Disease Deep Brain Stimulation Screening and the Relationship to Unintended Hospitalizations and Quality of Life.

Authors:  Masa-Aki Higuchi; Daniel Martinez-Ramirez; Hokuto Morita; Dan Topiol; Dawn Bowers; Herbert Ward; Lisa Warren; Meredith DeFranco; Julie A Hicks; Karen W Hegland; Michelle S Troche; Shankar Kulkarni; Erin Hastings; Kelly D Foote; Michael S Okun
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

3.  Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease.

Authors:  Simon D Israeli-Korn; Shraga Hocherman; Sharon Hassin-Baer; Oren S Cohen; Rivka Inzelberg
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.